11 Merchante N, Jimenez-Saenz M, Pineda J. Management of HCV-related end-stage liver disease in HIV-coinfected patients. AIDS Rev 2007; 9: 131–139. 12 Murillas J, Rimola A, Laguno M et al. for the ESLD-HIV Working Group Investigators. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study. Liver Transpl 2009; 15: 1133–1141. 13 Merchante N, Rivero-Juarez A, Tellez F et al. Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients
with compensated cirrhosis. Hepatology 2012; 56: 228–238. 14 Berretta M, Garlassi E, Cacopardo B et al. Hepatocellular carcinoma in HIV-infected patients: check early, treat hard. Oncologist 2011; 16: 1258–1269. 15 Bourcier V, Winnock M, Ait Ahmed M et al. for Anti-cancer Compound Library the ANRS CO13 Hepavih study group and ANRS CO12 Cirvir study group. Primary liver cancer is more aggressive in HIV-HCV coinfection than in HCV infection. A prospective study (ANRS CO13 Hepavih and CO12 Cirvir). Clin Res Hepatol Gastroenterol 2012; 36: 214–221. 16 Brau N, Fox R, Xiao P et al. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicentre study. J
click here Hepatol 2007; 47: 527–537. 17 Yopp AC, Subramanian M, Jain MK et al. Presentation, treatment, and clinical outcomes of patients with hepatocellular carcinoma, with and without human immunodeficiency virus infection. Clin Gastroenterol Hepatol 2012; 10: 1284–1290. 18 Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208–1236. 19 Chen J, Yang HI, Su J et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis
B virus DNA levels. JAMA 2006; 295: 65–73. 20 Clifford G, Rickenbach M, Polesel J et al. Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma. AIDS 2008; 22: 2135–2141. 21 El-Sarag H, Marremo J, Lenhard R, Reddy R. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 2008; 135: 1752–1763. 22 Vibert E, Duclos-Vallee Grape seed extract JC, Ghigna MR et al. Liver transplantation for hepatocellular carcinoma: the impact of human immunodeficiency virus infection. Hepatology 2011; 53: 475–482. 23 Zhang BH, Yang BH, Tang JY et al. Randomised controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004; 130: 417–422. 24 Soriano V, Miro J, Garcia-Smaniego J et al. Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations. J Viral Hepat 2004; 11: 2–17. 25 O’Grady J, Taylor C, Brook G. Guidelines for liver transplantation in patients with HIV infection (2005). HIV Med 2005; 6 (Suppl 2): 149–153. 26 Roland M, Stock P. Liver transplantation in HIV-infected recipients. Semin Liver Dis 2006; 26: 273–284. 27 Mindikoglu AL, Reger A, Magder LS.